TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search results
The clinical trials for a tuberculosis (TB) vaccine candidate developed with funding from the Gates Foundation are taking place in Indonesia under close monitoring by multiple national and international institutions and researchers, according to the Health Ministry.
The government plans to run clinical trials of several vaccines to curb the surging number of cases of tuberculosis (TB) this year, amid concerns the disease might affect economic growth, ministers said on Monday.
The Health Ministry has scrapped a complex set of rules prescribing which vaccine brands were to be used at which stages of the COVID-19 vaccination regimen, opting instead to allow people to get any generally approved vaccine for their primary and booster doses, as policymakers shift toward treating the coronavirus as an endemic disease.
As the world embraces life with COVID-19 entering the third year of the pandemic, countries in the Indo-Pacific seek commonalities for further collaboration to establish vaccine security as an anticipation for future plagues.
President Joko "Jokowi" Widodo has officially rolled out Indonesia's first developed COVID-19 vaccine Indovac for adult primary shots, instructing his administration to seek ways to achieve self-sufficiency in vaccines.
The government will start administering COVID-19 booster shots for free on Wednesday, President Joko “Jokowi” Widodo said, in an effort to strengthen the population’s immunity to the highly transmissible Omicron variant.
A property businesswoman in Medan, North Sumatra, has been sentenced to more than a year in prison and additional fines after a court found her guilty of illegally charging people for COVID-19 vaccines, the supply of which was secured by bribing state-employed doctors.
The government is simultaneously scaling up its efforts to procure COVID-19 vaccines, expand the national vaccine drive and impose new restrictions amid the surging transmission rate that is leaving hospitals and health workers overwhelmed.
Indonesian scientists developing vaccines are hoping to defend the country against the onslaught of COVID-19 but they still must deal with the same old issues that have long hampered research in the country, from overreliance on imported materials to lack of experience in downstreaming research products.
